UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Terminated
Unique ID issued by UMIN UMIN000018050
Receipt No. R000020659
Scientific Title International survey on the present status of integrative medicine and the approach for it.
Date of disclosure of the study information 2015/07/01
Last modified on 2017/06/25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title International survey on the present status of integrative medicine and the approach for it.
Acronym International survey of integrative medicine
Scientific Title International survey on the present status of integrative medicine and the approach for it.
Scientific Title:Acronym International survey of integrative medicine
Region
Japan Asia(except Japan) North America
South America Europe Africa

Condition
Condition adults aged 30 years or older with/without apparent illness
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the present status of integrative medicine and the approach for it in approximately 20 countries.
Basic objectives2 Others
Basic objectives -Others To consider the concept and the goal of integrative medicine
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes the similarity and the difference of integrative medicine between countries
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria 1. Those living in the relevant country for 10 years or more.
2. Those who are interested in integrative medicine.
Key exclusion criteria 1. Those who do not understand the meaning of this study.
2. Those who cannot answer the questionnaire of their own accord.
3. Those who are considered to be inappropriate as a participant.
Target sample size 1500

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kiyoshi Suzuki
Organization Gyokusenkai MOA Takanawa Clinic
Division name President
Zip code
Address 4-8-10 Takanawa, Minato-ku, Tokyo
TEL 03-5421-1945
Email k.suzuki@mhs.or.jp

Public contact
Name of contact person
1st name
Middle name
Last name Kiyoshi Suzuki
Organization Gyokusenkai MOA Takanawa Clinic
Division name President
Zip code
Address 4-8-4-8-10 Takanawa, Minato-ku, Tokyo
TEL 03-5421-1945
Homepage URL
Email k.suzuki@mhs.or.jp

Sponsor
Institute MOA Health Science Foundation, the general incorporated foundation
Institute
Department

Funding Source
Organization MOA Health Science Foundation, the general incorporated foundation
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 06 Month 23 Day
Date of IRB
Anticipated trial start date
2015 Year 07 Month 01 Day
Last follow-up date
2017 Year 12 Month 31 Day
Date of closure to data entry
2017 Year 12 Month 31 Day
Date trial data considered complete
2017 Year 12 Month 31 Day
Date analysis concluded
2018 Year 02 Month 28 Day

Other
Other related information 1. The team delivers a lecture to volunteer investigators in the relevant countries, explaining the purposes of the study and giving guidance on how to administer the questionnaires.
2. The investigators explain the meaning of this study to the participants, preferably government officers or doctors, and obtain the answer of the questionnaire.

Management information
Registered date
2015 Year 06 Month 23 Day
Last modified on
2017 Year 06 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020659

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.